BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8242637)

  • 1. Gene transfection and expression of the ovarian carcinoma marker folate binding protein on NIH/3T3 cells increases cell growth in vitro and in vivo.
    Bottero F; Tomassetti A; Canevari S; Miotti S; Ménard S; Colnaghi MI
    Cancer Res; 1993 Dec; 53(23):5791-6. PubMed ID: 8242637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein.
    Coney LR; Tomassetti A; Carayannopoulos L; Frasca V; Kamen BA; Colnaghi MI; Zurawski VR
    Cancer Res; 1991 Nov; 51(22):6125-32. PubMed ID: 1840502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography.
    Li PY; Del Vecchio S; Fonti R; Carriero MV; Potena MI; Botti G; Miotti S; Lastoria S; Menard S; Colnaghi MI; Salvatore M
    J Nucl Med; 1996 Apr; 37(4):665-72. PubMed ID: 8691264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
    Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
    Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate-binding protein is a marker for ovarian cancer.
    Campbell IG; Jones TA; Foulkes WD; Trowsdale J
    Cancer Res; 1991 Oct; 51(19):5329-38. PubMed ID: 1717147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of membrane folate-binding protein in the cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cell lines in vitro.
    Sen S; Erba E; D'Incalci M; Bottero F; Canevari S; Tomassetti A
    Br J Cancer; 1996 Feb; 73(4):525-30. PubMed ID: 8595169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression.
    Bagnoli M; Tomassetti A; Figini M; Flati S; Dolo V; Canevari S; Miotti S
    Oncogene; 2000 Sep; 19(41):4754-63. PubMed ID: 11032026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased growth of NIH/3T3 cells by transfection with human p120 complementary DNA and inhibition by a p120 antisense construct.
    Perlaky L; Valdez BC; Busch RK; Larson RG; Jhiang SM; Zhang WW; Brattain M; Busch H
    Cancer Res; 1992 Jan; 52(2):428-36. PubMed ID: 1728415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vivo mouse reporter gene (human secreted alkaline phosphatase) model to monitor ovarian tumor growth and response to therapeutics.
    Nilsson EE; Westfall SD; McDonald C; Lison T; Sadler-Riggleman I; Skinner MK
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):93-100. PubMed ID: 11862422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies.
    Figini M; Ferri R; Mezzanzanica D; Bagnoli M; Luison E; Miotti S; Canevari S
    Gene Ther; 2003 Jun; 10(12):1018-25. PubMed ID: 12776159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of ovarian carcinoma cell growth in vivo by the interferon-inducible plasma membrane protein, phospholipid scramblase 1.
    Silverman RH; Halloum A; Zhou A; Dong B; Al-Zoghaibi F; Kushner D; Zhou Q; Zhao J; Wiedmer T; Sims PJ
    Cancer Res; 2002 Jan; 62(2):397-402. PubMed ID: 11809687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of nuclear caveolin-1 to promoter elements of growth-associated genes in ovarian carcinoma cells.
    Sanna E; Miotti S; Mazzi M; De Santis G; Canevari S; Tomassetti A
    Exp Cell Res; 2007 Apr; 313(7):1307-17. PubMed ID: 17359972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of colony formation of NIH 3T3 cells by the expression of the small molecular weight heat shock protein HSP27: involvement of its phosphorylation and aggregation at the C-terminal region.
    Arata S; Hamaguchi S; Nose K
    J Cell Physiol; 1997 Jan; 170(1):19-26. PubMed ID: 9012781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of membrane-associated folate binding protein in the cytotoxicity of antifolates in KB, IGROV1, and L1210A cells.
    Schultz RM; Andis SL; Shackelford KA; Gates SB; Ratnam M; Mendelsohn LG; Shih C; Grindey GB
    Oncol Res; 1995; 7(2):97-102. PubMed ID: 7579732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19.
    Mantovani LT; Miotti S; Ménard S; Canevari S; Raspagliesi F; Bottini C; Bottero F; Colnaghi MI
    Eur J Cancer; 1994; 30A(3):363-9. PubMed ID: 8204360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.
    Weitman SD; Lark RH; Coney LR; Fort DW; Frasca V; Zurawski VR; Kamen BA
    Cancer Res; 1992 Jun; 52(12):3396-401. PubMed ID: 1596899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma.
    Mazzoni A; Mezzanzanica D; Jung G; Wolf H; Colnaghi MI; Canevari S
    Cancer Res; 1996 Dec; 56(23):5443-9. PubMed ID: 8968099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unidirectional potentiation of binding between two anti-FBP MAbs: evaluation of the involved mechanisms.
    Casalini P; Mezzanzanica D; Valota O; Adobati E; Tomassetti A; Colnaghi MI; Canevari S
    J Cell Biochem; 1995 May; 58(1):47-55. PubMed ID: 7642722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity.
    Holm J; Hansen SI; Høier-Madsen M; Birn H; Helkjaer PE
    Arch Biochem Biophys; 1999 Jun; 366(2):183-91. PubMed ID: 10356282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers.
    Peoples GE; Anderson BW; Lee TV; Murray JL; Kudelka AP; Wharton JT; Ioannides CG
    Clin Cancer Res; 1999 Dec; 5(12):4214-23. PubMed ID: 10632363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.